The Mt BirA sequence (UniProtKB entry code: P96884) was codon optimized (Bioneer) for optimal expression in E.coli, and cloned into pIM013 (pET-uvGFP) 13 to create pAC286 (pET-N-6HIS-MtbBirA-GFP-C). The Mt BirA-GFP was expressed in E. coli BL21(DE3)RIPL using Overnight Express TB Medium (Novagen) containing 100 μg/ml ampicillin as previously described. 14 The medium (100 ml in a 1 L conical flask) was inoculated with 1 mL of an overnight starter culture and incubated at 37 o C with shaking at 200 rpm until the optical density reached 0.5. The culture was then incubated for ~ 3 days at 16 o C. Lysis and purification procedures were performed as previously described for Ec BirA-GFP. 11 Protein concentration was determined by Bradford Assay and protein purity by SDS-PAGE.
Compound library
Compounds for protein stability screening were sourced from Compounds Australia, Griffith University (www.griffith.edu.au/science-aviation/compounds-australia). 
Compound screens with HT DSF-GTP
Ec BirA-GFP, Bp DnaB-GFP, Bp DnaG-GFP or RdRp-GFP were diluted to 1 µM in their respective buffers. Proteins (49 µl at 1 µM) were mixed with each compound (1 µl at 5 mM in DMSO) in separate wells of a 96-well clear PCR plate (Biorad, HSP9601).
One well containing only DMSO and one blank well were included as controls.
Reactions were incubated for 10 min at RT then heated in a real-time thermal cycler (IQ5 iCycler, Bio-Rad) from 30ºC-85ºC, increasing in 0.5ºC increments every 30 s.
Data was analysed as previously described. Following incubation, reactions were mixed with 4 µl GFP AviTag (375 µM in phosphate buffer) 11 and 26 µl biotinylation premix (0.96 mM biotin, 0.48 mM ATP, 1.92 mM MgCl2). Control reactions without GFP-AviTag and biotinylation buffer without BirA were also included. Reactions were incubated for a further 60 min at 37 ºC.
Unreacted biotin was then removed from the reaction using Profinity IMAC Nickel resin (Biorad) and Micro-Bio Spin Columns (Biorad) as previously described 11 . Reactions were bound to 50 µl pre-equilibrated nickel resin slurry for 5 min at 4ºC, then passed through the resin twice by centrifugation at 1000x g for 1 min at 4°C. The resin was washed twice with 500 µl of BirA buffer by centrifugation at 1000x g for 1 min at 4°C.
The proteins were eluted from the spin column with 75 µl of the same buffer supplemented with 200 mM imidazole and centrifugation at 1,000x g for 1 min at 4°C following 5 min incubation at 4°C. The eluate was then passed a second time through the same spin column as for first elution. All control reactions were processed in identical fashion for comparison to account for protein losses during purification and reaction steps and for normalization.
Affinity purified biotinylated GFP-AviTag (10 µl) was incubated with 1 µl Stv (5 mg/ml, Invitrogen) at room temperature for 15 min. Control reactions containing nonbiotinylated GFP-AviTag were not incubated with streptavidin. Reactions (10 µl) were mixed with non-reducing 2x SDS sample buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol blue), then subjected to 10% SDS-PAGE.
Biotinylation and inhibition of biotinylation by statins were detected by UV exposure of the gel post-migration as previously described. 
